ForSight Robotics, a company specializing in ophthalmic robotic surgery, has appointed Intuitive Surgical founder Dr. Fred Moll to its board of directors. This marks his first advisor role for an ophthalmology-focused surgical robotics company.

Dr. Moll founded Intuitive Surgical in the 1990s, pioneering robotic-assisted surgery and transforming minimally invasive procedures in dozens of specialties with its da Vinci surgical robot. He then founded Auris Health, which was acquired by Johnson & Johnson in 2019.

Most recently, Dr. Moll was chief development officer of J&J Medical Devices between 2019 and 2023. He has served on ForSight’s strategic advisory board since the company’s founding in 2020 and is a current investor in ForSight Robotics.

“Throughout my career, I have worked with medical robotics companies to improve healthcare access and outcomes for patients worldwide,” said Dr. Moll. “ForSight Robotics is advancing surgical robotics in eye care, helping to avoid preventable blindness and address the global shortage of ophthalmic surgeons. Having supported the company since its inception, I’m confident in its team, tools, and potential to reshape the industry. I’m proud to continue serving as a strategic advisor during this period of significant growth.”

“Dr. Moll’s incredible legacy of pioneering the surgical robotics category perfectly aligns with our mission to transform the future of eye surgery,” added Dr. Joseph Nathan, ForSight Robotics’ co-founder, president, and chief medical officer. “As we look to bring the ORYOM Platform, the world’s first platform for fully robotic cataract surgery, to market, Dr. Moll’s unparalleled expertise will be instrumental in accelerating our growth and shaping ophthalmic innovation.”

ForSight also recently hired Yonatan Ushpizin as VP of R&D and Ilanit Edri as VP of people, as well.

Ushpizin touts almost two decades of experience, serving at companies like Medtronic, Mazor Robotics, and Meytar R&D. He was most recently director of robotics research and technology at Medtronic.

Edri has over 25 years of experience in HR leadership roles in leading global organization. She was VP of human resources at Elbit Systems and VP of HR at The Open University of Israel. Further, Edri was head of HR for Teva Pharmaceuticals’ Global Generic R&D, for Tnuva Dairy, and for Medtronic Ventor.

“With the addition of Yonatan and Ilanit to our leadership team and the unparalleled guidance of Dr. Moll, ForSight is positioned to revolutionize ophthalmic surgery,” said Dr. Nathan. “Together, we are building a future where cutting-edge robotic surgery eradicates preventable blindness and sets new standards in surgical excellence; we are thrilled to lead the charge in transforming eye care worldwide.”